Skip to main content
Erschienen in: BMC Infectious Diseases 1/2019

Open Access 01.12.2019 | Case report

A case report of pulmonary Botrytis sp. infection in an apparently healthy individual

verfasst von: Seishu Hashimoto, Eisaku Tanaka, Masakuni Ueyama, Satoru Terada, Takashi Inao, Yusuke Kaji, Takehiro Yasuda, Takashi Hajiro, Tatsuo Nakagawa, Satoshi Noma, Gen Honjo, Yoichiro Kobashi, Noriyuki Abe, Katsuhiko Kamei, Yoshio Taguchi

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2019

Abstract

Background

Botrytis species are well known fungal pathogens of various plants but have not been reported as human pathogens, except as allergenic precipitants of asthma and hypersensitivity pneumonitis.

Case presentation

The asymptomatic patient was referred because of a nodule revealed by chest X-ray. Computed tomography (CT) showed a cavitary nodule in the right upper lobe of the lung. He underwent wedge resection of the nodule, which revealed necrotizing granulomas and a fungus ball containing Y-shaped filamentous fungi, which was confirmed histopathologically. Culture of the specimen yielded white to grayish cotton-like colonies with black sclerotia. We performed multilocus gene sequence analyses including three single-copy nuclear DNA genes encoding glyceraldehyde-3-phosphate dehydrogenase, heat-shock protein 60, and DNA-dependent RNA polymerase subunit II. The analyses revealed that the isolate was most similar to Botrytis elliptica. To date, the pulmonary Botrytis sp. infection has not recurred after lung resection and the patient did not require any additional medication.

Conclusions

We report the first case of an immunocompetent patient with pulmonary Botrytis sp. infection, which has not recurred after lung resection without any additional medication. Precise evaluation is necessary for the diagnosis of pulmonary Botrytis infection because it is indistinguishable from other filamentous fungi both radiologically and by histopathology. The etiology and pathophysiology of pulmonary Botrytis infection remains unclear. Further accumulation and analysis of Botrytis cases is warranted.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12879-019-4319-2) contains supplementary material, which is available to authorized users.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BLAST
Basic Local Alignment Search Tool
CGD
Chronic granulomatous disease
CT
Computed tomography
D1/D2
Domain 1 and 2
G3PDH
Glyceraldehyde-3-phosphate dehydrogenase
HSP60
Heat-shock protein 60
ITS
Internal transcribed spacer
MIC
Minimal inhibitory concentration
PCR
Polymerase Chain Reaction
PDA
Potato dextrose agar
RPB2
DNA-dependent RNA polymerase subunit II
rRNA
ribosomal ribonucleic acid

Background

Botrytis species are important pathogens of nursery plants, vegetables, orchard crops, and can colonize stored and transported agricultural products [1]. In particular, Botrytis cinerea is responsible for gray mold disease on more than 200 host plants [2] and has been isolated from numerous places around the world, especially humid, temperate and subtropical regions [13]. In contrast, winegrowers and viniculturists sometimes welcome B. cinerea, which facilitates a concentrated sweet wine in the right conditions. With regard to other Botrytis species, B. squamosa, B. allii, and B. aclada attack bulbs of onion, garlic and leek, while B. tulipae and B. elliptica attack flower bulbs such as tulip and lily.
Airborne exposure to Botrytis sp. has been reported globally but the prevalence of Botrytis is different by regions and seasons. Botrytis exposure is especially significant in occupational setting such as greenhouses and grain mills. Although many people may inhale spores of Botrytis species, it is of interest that Botrytis species have not been reported as human pathogens, except as allergenic precipitants of asthma and hypersensitivity pneumonitis [3].
We report an apparently immunocompetent Japanese man with pulmonary Botrytis sp. infection, which to date has not recurred after lung resection.
Preliminary results of this case report have been presented in a poster discussion at the annual meeting of the American Thoracic Society [4].

Case presentation

A 62-year-old Japanese man from Tenri City in Nara prefecture was referred to our hospital because of a nodular shadow on chest X-ray taken at a regular health checkup. He did not have cough, sputum, hemoptysis, fever, night sweats, chest pain and weight loss. He had smoked two packs of cigarettes per day for 30 years until 12 years previously and occasionally consumed alcohol. He was an office worker and had been to China and Taiwan on business for several days approximately 30 years previously. He had no known occupational or inhalational exposures. He had never grown any plants, fruits, or vegetables. He had diabetes mellitus, hyperlipidemia and gout and had been treated with a combination of mitiglinide and voglibose, vildagliptin, rosuvastatin, and allopurinol. He had no known tuberculosis, bronchiectasis, or allergies. Family history was unremarkable and there was no family history of fungal disease. On examination, his temperature was 36.4 °C, blood pressure 144/88 mmHg, and resting pulse was 85 beats per minute, with 12 breaths per minute. The oxygen saturation was 98% while breathing ambient air. He had normal vesicular sounds on auscultation. The remainder of the examination was normal.
A chest X-radiograph showed a cavitary nodule in the right upper lung field (Fig. 1b), which was not seen on X-ray film taken 18 months previously (Fig. 1a). Computed tomography (CT) revealed a nodule with cavitary lesion, measuring 25 mm in diameter, in the right upper lobe (Fig. 2a). 18F-fluorodeoxy-glucose positron emission tomography revealed mild accumulation in the nodule (maximum standardized uptake value = 2.2). Laboratory tests (Table 1) showed that serum creatinine was elevated at 1.2 mg/dL. The hemoglobin level, white cell and platelet counts, and results of coagulation and liver function were normal. C-reactive protein was below 0.2 mg/dL. The erythrocyte sedimentation rate was slightly elevated at 12 mm/h. Serum tests for 1, 3-β-D-glucan, Aspergillus antigen, anti-Aspergillus antibody, and Cryptococcus antigen were all negative. Hemoglobin A1c was normal at 5.6%. Both anti-human immunodeficiency virus antibody and anti-human T-cell leukemia virus type 1 antibody were negative. Bronchoscopic examination was performed, and bronchial brush specimens and bronchial washing fluids were obtained under fluoroscopy. However, the examination revealed no remarkable malignant cells or microorganisms including fungi and mycobacteria. Wedge resection of the cavitary nodule in the right upper lobe using video-assisted thoracoscopy was undergone to diagnose the nodule and exclude malignancy.
Table 1
Laboratory data
Variable
On Admission
Reference range, Adults
Hemoglobin (g/dl)
14.1
13.1–17.0
Hematocrit (%)
39.3
38.0–50.0
White cell count (per mm3)
6820
3500–8500
Differential count (%)
 Neutrophils
72
46–73
 Lymphocytes
23
20–45
 Monocytes
4
1–7
 Eosinophils
1
1–3
Platelet count (per mm3)
188,000
150,000-350,000
Erythrocyte sedimentation rate (mm/hour)
12
1–10
Blood urea nitrogen (mg/dl)
16
7–19
Creatinine (mg/dl)
1.2
0.6–1.2
Total protein (g/dl)
7.3
6.7–8.1
Albumin (g/dl)
4.4
4.0–5.0
Lactate dehydrogenase (U/liter)
213
100–225
Asparate aminotransferase (U/liter)
20
11–32
Alanine aminotransferase (U/liter)
18
3–30
Total bilirubin (mg/dl)
0.8
0.2–1.0
γ-Glutamyltransferase (U/liter)
28
10–60
Alkaline phosphatase (U/liter)
241
100–335
C-reactive protein (mg/dl)
<  0.2
<  0.2
Sodium (mmol/liter)
142
139–147
Potassium (mmol/liter)
4.1
3.5–4.8
Chloride (mmol/liter)
107
101–111
Blood sugar (mg/dl)
123
65–110
Prothrombin time (International normalized ratio)
1.00
0.86–1.12
Activated partial thromboplastin time (second)
27.3
23.0–35.0
Hemoglobin A1c (%)
5.8
4.3–6.1
Carcinoembryonic antigen (ng/ml)
2.8
<  5.0
Cytokeratin 19 fragment (ng/ml)
2.7
<  3.5
Progastrin-releasing peptide (pg/ml)
84.9
<  81
Soluble interleukin-2 receptor (U/ml)
434
145–519
1, 3-β-D-glucan (pg/dl)
<  5.5
<  11
Aspergillus antigen (cut off index)
<  0.1
<  0.5
Anti-Aspergillus antibody
Negative
Negative
Cryptococcus antigen
Negative
Negative
Anti-human immunodeficiency virus antibody (cut off index)
0.16
<  1.0
Anti-human T-cell leukemia virus type 1 antibody (cut off index)
0.09
<  1.0
Histopathological examination of the resected specimen showed necrotizing granulomas and a fungus ball containing Y-shaped filamentous fungi (Fig. 2b-f). Grocott’s methenamine silver stain revealed that the septated hyphae branched dichotomously (Fig. 2g). Vascular invasion was not seen in the tissue. The histopathological features resembled those of chronic cavitary pulmonary aspergillosis.
The lung biopsy material was cultured for fungi, mycobacteria and other bacteria. Because molds were observed in the intraoperative frozen section, culture for fungi was incubated at 25 °C on potato dextrose agar (PDA) for 7 days. The culture yielded white to grayish cotton-like colonies with black sclerotia around the colonies (Fig. 3a). No other microorganisms were isolated. The multilocus gene sequence analyses identified the fungus as Botrytis sp. as shown in Tables 2, 3, 4 and Additional file 1: Figures S1-S5. He was diagnosed with pulmonary Botrytis sp. infection. As the patient was immunocompetent and the completely resected specimen showed necrotizing granulomas without vascular invasion, he was not offered antifungal agents. The pulmonary Botrytis sp. infection has not recurred 3 years after resectional surgery (Fig. 4).
Table 2
List of primers employed in polymerase chain reaction in this study
Target Region
Primer Name
Primer Sequence (5’ to 3’)
Reference
ITS
ITS1
TCCGTAGGTGAACCTGCGG
[4]
ITS4
TCCTCCGCTTATTGATATGC
Domain 1 and 2
NL-1
GCATATCAATAAGCGGAGGAAAAG
[5]
NL-4
GGTCCGTGTTTCAAGACGG
G3PDH
G3PDHfor
ATTGACATCGTCGCTGTCAACGA
[6]
G3PDHrev
ACCCCACTCGTTGTCGTACCA
HSP60
HSP60for
CAACAATTGAGATTTGCCCACAAG
[6]
HSP60rev
GATGGATCCAGTGGTACCGAGCAT
RPB2
RPB2for
GATGATCGTGATCATTTCGG
[6]
RPB2rev
CCCATAGCTTGCTTACCCAT
Table 3
BLAST results of sequences at internal transcribed spacer (ITS) region and domain 1 and 2 region
 
ITSfor
ITSrev
Domain 1 and 2for
Domain 1 and 2rev
1
Botryotinia fuckeliana
Botrytis cinerea
Botrytis cinerea
Botrytis cinerea
Identities
489/491 (99%)
482/483 (99%)
559/560 (99%)
558/559 (99%)
Accession no.
KF533033.1
MF521935.1
KU140653.1
KU729179.1
2
Botrytis fabiopsis
Botrytis cinerea
Botrytis cinerea
Botrytis cinerea
Identities
489/491 (99%)
482/483 (99%)
559/560 (99%)
558/559 (99%)
Accession no.
KR135152.1
KU291996.1
KR094468.1
KT323330.1
3
Botrytis elliptica
Botrytis cinerea
Botrytis cinerea
Botrytis cinerea
Identities
489/491 (99%)
482/483 (99%)
559/560 (99%)
558/559 (99%)
Accession no.
KR055047.1
KT271762.1
KP671724.1
KR094468.1
4
Botrytis cinerea
Botrytis elliptica
Botrytis cinerea
Botrytis cinerea
Identities
489/491 (99%)
483/484 (99%)
559/560 (99%)
558/559 (99%)
Accession no.
KR002909.1
KR055047.1
CP009808.1
KP780471.1
5
Botrytis cinerea
Botrytis elliptica
Botrytis cinerea
Botrytis cinerea
Identities
489/491 (99%)
483/484 (99%)
559/560 (99%)
558/559 (99%)
Accession no.
KF859919.1
KR076789.1
KM249092.1
KP671724.1
Table 4
BLAST results of sequences at glyceraldehyde-3-phosphate dehydrogenase (G3PDH), heat-shock protein 60 (HSP60) and DNA-dependent RNA polymerase subunit II (RPB2) genes
 
G3PDHfor
G3PDHrev
HSP60for
HSP60rev
RPB2for
RPB2rev
1
B. elliptica
B. elliptica
B. elliptica
B. elliptica
B. elliptica
B. elliptica
Identities
924/928
(99%)
924/929
(99%)
988/988
(100%)
981/983
(99%)
961/963
(99%)
992/993
(99%)
Accession no.
KP896523.1
KP896523.1
KR076786.1
KR076786.1
KR076787.1
KR076787.1
2
B. squamosa
B. squamosa
B. squamosa
B. squamosa
B. elliptica
B. elliptica
Identities
880/884
(99%)
882/886
(99%)
975/976
(99%)
974/977
(99%)
961/963
(99%)
965/966
(99%)
Accession no.
AJ705037.1
AJ705037.1
FJ169659.1
FJ169659.1
AJ745682.1
AJ745682.1
3
B. ficariarum
B. ficariarum
B. squamosa
B. squamosa
B. squamosa
B. squamosa
Identities
880/884
(99%)
882/886
(99%)
975/976
(99%)
974/977
(99%)
960/963
(99%)
964/966
(99%)
Accession no.
AJ705016.1
AJ705016.1
AJ716098.1
AJ716098.1
FJ169682.1
FJ169682.1
4
B. elliptica
B. elliptica
B. elliptica
B. elliptica
B. squamosa
B. squamosa
Identities
880/884
(99%)
882/886
(99%)
975/976
(99%)
974/977
(99%)
960/963
(99%)
964/966
(99%)
Accession no.
AJ705010.1
AJ705010.1
AJ716071.1
AJ716071.1
AJ745707.1
AJ745707.1
5
B. squamosa
B. squamosa
B. elliptica
B. elliptica
B. elliptica
B. elliptica
Identities
879/884
(99%)
881/886
(99%)
974/976
(99%)
973/977
(99%)
958/963
(99%)
962/966
(99%)
Accession no.
EU519214.1
EU519214.1
AM232669.1
AM232669.1
EU514477.1
EU514477.1

Mycological features of isolated Botrytis species

The light microscopy findings stained with lactophenol cotton-blue showed that the mycelium was branched with septa and the conidiophores were also septated. The conidia were single-celled with egg-shaped hyaline and the diameter ranged from approximately 2–3 × 5–8 μm (Fig. 3b). A growth temperature test was performed with incubation on PDA for 7 days at 25 °C and 35 °C. The growth of the colonies was observed at 25 °C but not at 35 °C.
Multilocus gene sequence analyses targeting the internal transcribed spacer (ITS) 1 and 2 region and domain 1 and 2 (D1/D2) region of 28S rRNA were performed for species identification. The genomic DNA of this isolate was prepared using Go Taq® Green Master Mix (Promega Corporation, WI, USA), and PCR was carried out in a Veriti® 96-Well Thermal Cycler (Thermo Fisher Scientific K.K., Yokohama, Japan). The PCR was performed using the primer pair ITS1 and ITS4 for the ITS region, and the primer pair NL-1 and NL-4 for the D1/D2 region (Table 2) [5, 6]. Sanger sequencing data of the PCR products were compared with those of the GenBank database search using BLAST. The isolate had 99% similarity to sequences from B. cinerea, its teleomorph (Botryotinia fuckeliana), B. fabiopsis and B. elliptica at the ITS region, and B. cinerea at the D1/D2 region (see Additional file 1: Figures S1 and S2, and Table 3).
As the sequences of ITS and D1/D2 regions do not permit sufficient resolution to the species level in the genus Botrytis [7], we further analyzed three single-copy nuclear DNA genes encoding glyceraldehyde-3-phosphate dehydrogenase (G3PDH), heat-shock protein 60 (HSP60), and DNA-dependent RNA polymerase subunit II (RPB2), which are known to be more discriminatory in attaining the Botrytis species level. The PCR was performed using the primer pairs G3PDHfor/G3PDHrev, HSP60for/HSP60rev and RPB2for/RPB2rev for G3PDH, HSP60 and RPB2, respectively (Table 2) [7]. The PCR products were sequenced and the result of the GenBank database search using BLAST showed that the isolate was most similar to B. elliptica (see Additional file 1: Figures S3-S5 and Table 4).
The antifungal susceptibility test of the isolated Botrytis species was performed using the broth microdilution assay according to the Clinical and Laboratory Standards Institute approved standard M38-A2 guideline for molds. We tried to evaluate the minimal inhibitory concentration (MIC) of antifungal agents including amphotericin B, micafungin, voriconazole, fluconazole, itraconazole, miconazole, and flucytosine. No growth was observed at any MIC for any antifungal agents including the control media.

Discussion and conclusions

This case is the first report of an apparently immunocompetent patient with pulmonary Botrytis sp. infection, which has not recurred after lung resection. Furthermore, the patient did not require any additional medication.
Botrytis species are well known fungal pathogens of various plants and agricultural products but little is known about their pathogenicity in humans. Two clinical studies reported an association between asthma and positive skin prick test reaction to molds including B. cinerea [8, 9]. Korhonen [8] reported that the most common responsive molds were B. cinerea, Aspergillus fumigatus and Cladosporium herbarum in young Finnish children newly diagnosed with asthma. Immonen [9] found that allergy toward B. cinerea is just as prevalent as allergy toward A. fumigatus, Alternaria alternata, and C. herbarum in Finnish school children having asthma or in those suspected of asthma. Specific IgE antibodies to molds were investigated using a standard mold test panel (Phadebas RAST®) and an extended mold panel, in which B. cinerea was included, in two studies [10, 11]. Karlsson-Borgå [10] reported that B. cinerea was the second most prevalent mold allergen in Sweden and Denmark, and the most prevalent in the USA in patients with suspected mold allergy. Koivikko [11] found that B. cinerea was the fourth most prevalent fungal allergy in 121 asthmatic children. Similar to other fungi, B. cinerea contains 1, 3-β-D-glucan and chitin in its cell wall. Studies have shown that inhalation of this particular 1, 3-β-D-glucan can elicit respiratory inflammation and chitin might also be involved in allergic reactions upon frequent exposure to this polysaccharide [3].
Cases of hypersensitivity pneumonitis/allergic alveolitis caused by B. cinerea have been reported in two farm workers working with noble rot grapes (wine grower’s lung) [12]. They inhaled spores of B. cinerea during grape gathering. Their chest radiograph showed a reticular shadow indicative of pulmonary fibrosis. B. cinerea specific IgG antibody was identified using the Ouchterlony immunodiffusion test and the immunofluorescence test in both patients.
There have been no reports of Botrytis infection in humans even though many people likely inhale spores of Botrytis species. Detection of saprophytic molds from sputum or bronchoalveolar lavage samples has generally been considered as contamination or colonization [13]. In our case Botrytis was detected in pure culture from a resected lung nodule. Fungal infections occur in patients with risk factors such as environmental factors, primary or acquired immunodeficiency, and structural lung diseases. Our patient had not stayed or worked in an environment where significant exposure to spores of Botrytis species was likely. He had diabetes mellitus, which is a known risk factor for fungal infections [14], but the patient’s diabetes was strictly controlled and hemoglobin A1c was normal. He did not have diseases causing immunosuppression such as acquired immunodeficiency syndrome or hematological malignancy, and took neither corticosteroids, nor cytotoxic agents. Recently, biological defense mechanisms against fungal infections have been elucidated [15] and primary immunodeficiencies including chronic granulomatous disease (CGD) or caspase recruitment domain family member 9 deficiency can also predispose to invasive fungal diseases [16]. Although we did not test for CGD or other genetic markers that may confer susceptibility, he had never experienced any fungal infections until this presentation and his family also had no fungal infections. Pulmonary aspergillosis that is unrelated to immunosuppression requires previous airway damage, such as bronchiectasis or bullous disease. This patient had a history of 60 pack-years of smoking cigarettes. The fungus ball can be formed by proliferation of fungi saprophytically in emphysematous bulla. This could not be demonstrated because he had not received a CT scan prior to his clinical presentation within our hospital.
Alternatively, Botrytis lung infection may have been misdiagnosed as Aspergillus infection, when we found Y-shaped filamentous fungi with septa in the resected lung tissue histopathologically without microbiological examination.
The antifungal susceptibility test of the isolated Botrytis species was performed using the Clinical and Laboratory Standards Institute M38-A2 broth microdilution method. No growth was observed at any MIC for any of the antifungal agents including the control media. We tried to incubate the isolate in liquid media including Roswell Park Memorial Institute media 1640 and Sabouraud liquid broth media, but no growth was observed (data not shown). This suggests that the isolated Botrytis species may be difficult to incubate in liquid media.
In conclusion, we report the first case of an apparently immunocompetent patient with pulmonary Botrytis sp. infection, which has not recurred after lung resection without any additional medication. Precise evaluation is necessary for the diagnosis of pulmonary Botrytis infection, because it is indistinguishable from other filamentous fungi both radiologically and by histopathology. Furthermore, the etiology and pathophysiology of pulmonary Botrytis infection remains unclear. Further accumulation and analysis of Botrytis cases is warranted.

Acknowledgements

Not applicable.
Not applicable.
Written consent from the patient was obtained for publication of this case report.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Elad Y, Williamson B, Tudzynski P, Delen N. Botrytis: Biology, pathology and control. Netherland: Springer; 2007.CrossRef Elad Y, Williamson B, Tudzynski P, Delen N. Botrytis: Biology, pathology and control. Netherland: Springer; 2007.CrossRef
2.
Zurück zum Zitat Williamson B, Tudzynski B, Tudzynski P, van Kan JA. Botrytis cinerea: the cause of grey mould disease. Mol Plant Pathol. 2007;8(5):561–80.CrossRef Williamson B, Tudzynski B, Tudzynski P, van Kan JA. Botrytis cinerea: the cause of grey mould disease. Mol Plant Pathol. 2007;8(5):561–80.CrossRef
3.
Zurück zum Zitat Jurgensen CW, Madsen A. Exposure to the airborne mould Botrytis and its health effects. Ann Agric Environ Med. 2009;16(2):183–96.PubMed Jurgensen CW, Madsen A. Exposure to the airborne mould Botrytis and its health effects. Ann Agric Environ Med. 2009;16(2):183–96.PubMed
4.
Zurück zum Zitat Hashimoto S, Tanaka E, Ueyama M, Terada S, Nakanishi T, Hamao H, et al. A case of pulmonary Botrytis species infection in an apparently healthy individual [abstract]. Am J Respir Crit Care Med. 2017;195:A7155. Hashimoto S, Tanaka E, Ueyama M, Terada S, Nakanishi T, Hamao H, et al. A case of pulmonary Botrytis species infection in an apparently healthy individual [abstract]. Am J Respir Crit Care Med. 2017;195:A7155.
5.
Zurück zum Zitat White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. London: Academic; 1990. p. 315–22. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. London: Academic; 1990. p. 315–22.
6.
Zurück zum Zitat Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol. 1997;35(5):1216–23.PubMedPubMedCentral Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5’ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol. 1997;35(5):1216–23.PubMedPubMedCentral
7.
Zurück zum Zitat Staats M, van Baarlen P, van Kan JA. Molecular phylogeny of the plant pathogenic genus Botrytis and the evolution of host specificity. Mol Biol Evol. 2005;22(2):333–46.CrossRef Staats M, van Baarlen P, van Kan JA. Molecular phylogeny of the plant pathogenic genus Botrytis and the evolution of host specificity. Mol Biol Evol. 2005;22(2):333–46.CrossRef
8.
Zurück zum Zitat Korhnen K, Mähönen S, Hyvärinen A, Nevalainen A, Husman T, Pekkanen J, et al. Skin test reactivity to molds in pre-school children with newly diagnosed asthma. Pediatr Int. 2006;48(6):577–81.CrossRef Korhnen K, Mähönen S, Hyvärinen A, Nevalainen A, Husman T, Pekkanen J, et al. Skin test reactivity to molds in pre-school children with newly diagnosed asthma. Pediatr Int. 2006;48(6):577–81.CrossRef
9.
Zurück zum Zitat Immonen J, Meklin T, Taskinen T, Nevalainen A, Korppi M. Skin-prick test findings in students from moisture- and mould-damaged schools: a 3-year follow-up study. Pediatr Allergy Immunol. 2001;12(2):87–94.CrossRef Immonen J, Meklin T, Taskinen T, Nevalainen A, Korppi M. Skin-prick test findings in students from moisture- and mould-damaged schools: a 3-year follow-up study. Pediatr Allergy Immunol. 2001;12(2):87–94.CrossRef
10.
Zurück zum Zitat Karlsson-Borgå A, Jonsson P, Rolfsen W. Specific IgE antibodies to 16 widespread mold genera in patients with suspected mold allergy. Ann Allergy. 1989;63(6):521–6.PubMed Karlsson-Borgå A, Jonsson P, Rolfsen W. Specific IgE antibodies to 16 widespread mold genera in patients with suspected mold allergy. Ann Allergy. 1989;63(6):521–6.PubMed
11.
Zurück zum Zitat Koivikko A, Viander M, Lanner A. Use of the extended Phadebas RAST panel in the diagnosis of mould allergy in asthmatic children. Allergy. 1991;46(2):85–91.CrossRef Koivikko A, Viander M, Lanner A. Use of the extended Phadebas RAST panel in the diagnosis of mould allergy in asthmatic children. Allergy. 1991;46(2):85–91.CrossRef
12.
Zurück zum Zitat Popp W, Ritschka L, Zwick H, Rauscher H. “Berry sorter’s lung” or wine grower’s lung – an exogenous allergic alveolitis caused by Botrytis cinerea spores. Prax Klin Pneumol. 1987;41(5):165–9.PubMed Popp W, Ritschka L, Zwick H, Rauscher H. “Berry sorter’s lung” or wine grower’s lung – an exogenous allergic alveolitis caused by Botrytis cinerea spores. Prax Klin Pneumol. 1987;41(5):165–9.PubMed
13.
Zurück zum Zitat Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–e38.CrossRef Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–e38.CrossRef
14.
Zurück zum Zitat Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.CrossRef Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906–12.CrossRef
15.
Zurück zum Zitat Holland SM, Vinh DC. Yeast infections--human genetics on the rise. N Engl J Med. 2009;361(18):1798–801.CrossRef Holland SM, Vinh DC. Yeast infections--human genetics on the rise. N Engl J Med. 2009;361(18):1798–801.CrossRef
16.
Zurück zum Zitat Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22(8):681–7.CrossRef Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22(8):681–7.CrossRef
Metadaten
Titel
A case report of pulmonary Botrytis sp. infection in an apparently healthy individual
verfasst von
Seishu Hashimoto
Eisaku Tanaka
Masakuni Ueyama
Satoru Terada
Takashi Inao
Yusuke Kaji
Takehiro Yasuda
Takashi Hajiro
Tatsuo Nakagawa
Satoshi Noma
Gen Honjo
Yoichiro Kobashi
Noriyuki Abe
Katsuhiko Kamei
Yoshio Taguchi
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2019
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4319-2

Weitere Artikel der Ausgabe 1/2019

BMC Infectious Diseases 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.